CCORF Maintains Opus Genetics(IRD.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsNov 13 08:36 ET · Ratings

Opus Genetics: Promising Future With Key Data Readouts and Strong Financial Position Justify Buy Rating

TipRanksNov 13 08:27 ET · Ratings

Opus Genetics Reinstated With a Buy at H.C. Wainwright

TipRanksNov 13 06:40 ET · Ratings

JonesTrading Maintains Opus Genetics(IRD.US) With Buy Rating, Maintains Target Price $9

Moomoo NewsNov 12 13:32 ET · Ratings

Opus Genetics | 10-Q: Q3 2024 Earnings Report

SECNov 12 09:40 ET · Announcements

Ocuphire Pharma GAAP EPS of -$0.29 Misses by $0.05, Revenue of $3.87M Beats by $1.57M

Seeking AlphaNov 12 08:22 ET